Wall Street flat; J&J report pressures pharma sector

US equities closed flat in a quiet session, with the only notable move a decline in pharmaceutical stocks following Johnson & Johnson's earnings report. The specific figures and the extent of the sector-wide impact remain unclear, but the move suggests a company-specific disappointment rather than a broad market shift.